Literature DB >> 27602154

Proteomic profile of saliva and plasma from women with impalpable breast lesions.

Lucas Delmonico1, Maryah Bravo2, Rafaele Tavares Silvestre1, Maria Helena Faria Ornellas3, Carolina Maria De Azevedo4, Gilda Alves1.   

Abstract

The present study evaluated the proteomic profile of saliva and plasma from women with impalpable breast lesions using nano-liquid chromatography-quadrupole-time-of-flight (nLC-Q-TOF) technology. Plasma and saliva from patients with fibroadenoma (n=10), infiltrating ductal carcinoma (n=10) and healthy control groups (n=8) were assessed by combinations of inter/intra-group analyses, revealing significant quantitative and qualitative differences. The major differentially-expressed proteins in the saliva of patients compared with the controls were α2-macroglobulin and ceruloplasmin, but the proteins that met the minimum fold-change and P-value cut-offs were leukocyte elastase inhibitor and α-enolase, and deleted in malignant brain tumors 1. Concerning plasma, α-2-macroglobulin and ceruplasmin were upregulated, while other proteins such as haptoglobin, hemopexin and vitamin D-binding protein were downregulated compared with the control. The changes in immune, molecular transport and signaling pathways were the most representative in the proteomic profile of the saliva and plasma. This is the first study to describe the proteome of saliva and plasma from the same women with impalpable breast lesions.

Entities:  

Keywords:  circulating biomarkers; impalpable breast lesions; plasma; proteomics; saliva

Year:  2016        PMID: 27602154      PMCID: PMC4998569          DOI: 10.3892/ol.2016.4828

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

Authors:  Chafika Mazouni; Keith Baggerly; David Hawke; Spyros Tsavachidis; Fabrice André; Aman U Buzdar; Pierre-Marie Martin; Ryuji Kobayashi; Lajos Pusztai
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

2.  Comparison of protein enrichment strategies for proteome analysis of plasma.

Authors:  Julia E Bandow
Journal:  Proteomics       Date:  2010-04       Impact factor: 3.984

3.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

4.  CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable breast lesions.

Authors:  Lucas Delmonico; Aline dos Santos Moreira; Marco Felipe Franco; Eliane Barbosa Esteves; Luciano Scherrer; Claúdia Vitória de Moura Gallo; Cristina Moreira do Nascimento; Maria Helena Faria Ornellas; Carolina Maria de Azevedo; Gilda Alves
Journal:  Hum Pathol       Date:  2015-07-02       Impact factor: 3.466

5.  Procedures for location of non-palpable breast lesions: a systematic review for the radiologist.

Authors:  Roberta Fusco; Antonella Petrillo; Orlando Catalano; Mario Sansone; Vincenza Granata; Salvatore Filice; Massimiliano D'Aiuto; Quentin Pankhurst; Michael Douek
Journal:  Breast Cancer       Date:  2012-11-02       Impact factor: 4.239

6.  Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.

Authors:  Meike de Wit; Huub Kant; Sander R Piersma; Thang V Pham; Sandra Mongera; Maaike P A van Berkel; Epie Boven; Fredrik Pontén; Gerrit A Meijer; Connie R Jimenez; Remond J A Fijneman
Journal:  J Proteomics       Date:  2014-01-10       Impact factor: 4.044

7.  Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping.

Authors:  Jean E Abraham; Mel J Maranian; Inmaculada Spiteri; Roslin Russell; Susan Ingle; Craig Luccarini; Helena M Earl; Paul P D Pharoah; Alison M Dunning; Carlos Caldas
Journal:  BMC Med Genomics       Date:  2012-05-30       Impact factor: 3.063

8.  Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

Authors:  Lei Zhang; Hua Xiao; Scott Karlan; Hui Zhou; Jenny Gross; David Elashoff; David Akin; Xinmin Yan; David Chia; Beth Karlan; David T Wong
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

9.  Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

Authors:  Charles F Streckfus; Daniel Arreola; Cynthia Edwards; Lenora Bigler
Journal:  J Oncol       Date:  2012-04-10       Impact factor: 4.375

10.  Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.

Authors:  Ya Yang; Nelson L Rhodus; Frank G Ondrey; Beverly R K Wuertz; Xiaobing Chen; Yaqin Zhu; Timothy J Griffin
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more
  6 in total

1.  Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment.

Authors:  Talita Mendes Oliveira Ventura; Nathalia Regina Ribeiro; Even Akemi Taira; Aline de Lima Leite; Aline Dionizio; Cássia Maria Fischer Rubira; Paulo Sérgio da Silva Santos; Marília Afonso Rabelo Buzalaf
Journal:  Clin Oral Investig       Date:  2021-05-29       Impact factor: 3.573

Review 2.  HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers.

Authors:  Peilong Li; Nan Wang; Yi Zhang; Chuanxin Wang; Lutao Du
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

3.  Metabolic Features of Saliva in Breast Cancer Patients.

Authors:  Lyudmila V Bel'skaya; Elena A Sarf; Denis V Solomatin; Victor K Kosenok
Journal:  Metabolites       Date:  2022-02-10

Review 4.  Salivary biomarkers and proteomics: future diagnostic and clinical utilities.

Authors:  M Castagnola; E Scarano; G C Passali; I Messana; T Cabras; F Iavarone; G Di Cintio; A Fiorita; E De Corso; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

Review 5.  Saliva proteomics updates in biomedicine.

Authors:  Katerina R Katsani; Dimitra Sakellari
Journal:  J Biol Res (Thessalon)       Date:  2019-12-12       Impact factor: 1.889

6.  In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression.

Authors:  Lucia Santorelli; Giulia Capitoli; Clizia Chinello; Isabella Piga; Francesca Clerici; Vanna Denti; Andrew Smith; Angelica Grasso; Francesca Raimondo; Marco Grasso; Fulvio Magni
Journal:  Cancers (Basel)       Date:  2020-01-18       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.